Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
European Journal of Gastroenterology & Hepatology|May 9, 2013
Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effectErin M Kelly, Curtis L CooperClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfectionCurtis L Cooper, D William CameronHarm Reduction Journal|November 14, 2006
Therapeutic challenges in hepatitis C-infected injection drug using patientsCurtis L Cooper, Edward J MillsAIDS (London, England)|April 13, 2004
Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infectionCurtis L Cooper, D William CameronHIV Clinical Trials|December 13, 2006
Infection rates in HIV-HCV patients treated with interferon are similar to those in HCV mono-infection and not related to neutropeniaCurtis L Cooper, Saif Al-BedwawiCase Reports in Infectious Diseases|October 23, 2018
An Evaluation of Rapidly Progressive Dementia Culminating in a Diagnosis of Creutzfeldt-Jakob DiseaseParmvir Parmar, Curtis L Cooper, Daniel KobewkaCanadian Liver Journal|July 18, 2025
Increased Alkaline Phosphatase Associated with Brown Algae and Mushroom Extract-Containing Supplement UseHimain Perera, Christopher McCudden, Curtis L CooperEuropean Journal of Gastroenterology & Hepatology|July 23, 2014
Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infectionAngela Assal, David Mackie, Curtis L CooperAIDS (London, England)|December 7, 2006
Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infectionCurtis L Cooper, Edward Mills, Jonathan B AngelClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2008
Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or deathCecilia T Costiniuk, Fernando Camacho, Curtis L CooperPageof 13